세계 맘모그래피 시장의 성장 주요인은 유방암 이환율 증가, 유방 영상 진단 분야의 기술적 진보, 유방암 검진 캠페인에 대한 다양한 조직의 투자 등입니다.
세계의 맘모그래피(Mammography) 시장을 조사했으며, 전체적인 시장 동향, 제품 유형·최종사용자·지역별 상세 동향, 시장 성장 영향요인 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 종합적으로 정리했습니다.
1서론
2 조사 방법
3 주요 요약
4 시장 역학
5 시장 세분화
6 경쟁 구도
7 시장 기회 및 향후 동향
LSH 19.03.25※ 이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.
The major factors responsible for the growth of the mammography market include the growing prevalence of breast cancer, technological advancements in the field of breast imaging, and investment from various organizations in breast cancer screening campaigns.
The Digital Mammography Segment is Expected to Account for the Largest Market Share During the Forecast Period
Digital mammography is a specialized and advanced form of mammography that uses digital receptors and computers instead of X-ray films to examine breast tissue for the presence of tumors. So far, conventional screen-film mammography (SFM) with high-spatial resolution has been the preferred choice for screening programs in most countries. However, with the advent of digital mammography, an increasing number of countries are experiencing shifts toward these newer systems, due to their superior depiction of low-contrast objects, wider dynamic change, and improved diagnostic quality of images, especially when examining denser breasts. They also come with an added advantage of soft-copy image displays and soft-copy reading, which can be easily transferred. Mammography screening in various countries, such as in the United Kingdom, is now digital, which offers greater precision, better quality, and higher efficiency. Thus, digital mammography is becoming the preferred choice of screening, even though the cost of the new technology is six times higher than the conventional systems. Radiation exposure is significantly lower as compared to analog systems. Full-field digital mammography is the most common form of digital mammography employed. It offers the potential for significant advances in breast cancer diagnosis, including lower radiation dosages, reduced breast compression pressure, and improved detection. All these advantages aid in the growth of the market over the forecast period.
North America Accounts for the Largest Share in the Global Market
North America is found to hold a major share for the mammography market, and it is expected to show a similar trend over the forecast period, without significant fluctuations. The rising prevalence of breast cancer and the presence of better healthcare infrastructure in the region are expected to drive the overall growth of the market over the forecast period.
As per the estimates of Breastcancer.org, an estimated 268,600 new cases of invasive breast cancer were diagnosed in women in the United States in 2019. Furthermore, there is a rise in funding activity for research in breast cancer. For instance, according to the NCI budget factbook, breast cancer received funding of USD 545.1 million in 2017. In the United States, the National Breast Cancer Foundation (NBCF) is the organization that provides breast cancer education and free mammograms to women in need. This organization conducts various programs, such as National Mammography Program, Beyond The Shock, Patient Navigation, and Breast Health Awareness. Thus, owing to the rising prevalence of breast cancer and awareness among the population, the market is expected to experience growth over the forecast period.
The mammography market is a consolidated one, owing to the presence of a few major players in the market. The major market players are focusing on technological advancements and reducing the side effects of the procedures. Some of the major players in the market are Analogic Corporation, Canon Medical Systems Corporation, Fujifilm Corporation, GE Healthcare, Hologic Inc., Koninklijke Philips NV, and Siemens Healthineers.